TY - JOUR
T1 - Upregulation of MUC4 in cervical squamous cell carcinoma
T2 - Pathologic significance
AU - Munro, Elizabeth G.
AU - Jain, Maneesh
AU - Oliva, Esther
AU - Kamal, Neel
AU - Lele, Subodh M.
AU - Lynch, Maureen P.
AU - Guo, Lankai
AU - Fu, Kai
AU - Sharma, Poonam
AU - Remmenga, Steve
AU - Growdon, Whitfield B.
AU - Davis, John S.
AU - Rueda, Bo R.
AU - Batra, Surinder K.
PY - 2009/3
Y1 - 2009/3
N2 - MUC4 is a transmembrane glycoprotein more highly expressed in cervical dysplasia than benign cervical epithelium. We sought to determine whether MUC4 expression differs between benign and malignant cervical tissue. Fifty-eight patients with benign, dysplastic, or malignant cervical pathology were identified retrospectively, and representative sections were stained with a mouse monoclonal anti-MUC4 antibody. Semiquantitative analysis was performed on benign, dysplastic, and malignant regions by scoring staining intensity (0: negative, 1: weak, 2: moderate, and 3: strong) and distribution (focal
AB - MUC4 is a transmembrane glycoprotein more highly expressed in cervical dysplasia than benign cervical epithelium. We sought to determine whether MUC4 expression differs between benign and malignant cervical tissue. Fifty-eight patients with benign, dysplastic, or malignant cervical pathology were identified retrospectively, and representative sections were stained with a mouse monoclonal anti-MUC4 antibody. Semiquantitative analysis was performed on benign, dysplastic, and malignant regions by scoring staining intensity (0: negative, 1: weak, 2: moderate, and 3: strong) and distribution (focal
UR - http://www.scopus.com/inward/record.url?scp=68949200944&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68949200944&partnerID=8YFLogxK
U2 - 10.1097/PGP.0b013e318184f3e0
DO - 10.1097/PGP.0b013e318184f3e0
M3 - Article
C2 - 19188823
AN - SCOPUS:68949200944
SN - 0277-1691
VL - 28
SP - 127
EP - 133
JO - International Journal of Gynecological Pathology
JF - International Journal of Gynecological Pathology
IS - 2
ER -